Sionna Therapeutics, Inc. Common Stock (SION)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $141.13M
Last updated: Nov 17, 2026 at 4:15 PM ET
Sionna Therapeutics, Inc. Common Stock (SION) Statistics
Sionna Therapeutics, Inc. Common Stock (SION) has a market cap of $141.13M and an enterprise value of $57.26M. It holds $83.88M more cash than debt, 59.43% of its market cap.
Total Valuation
Enterprise value is 59.43% below the market cap, as cash exceeds debt.
| Market Cap | $141.13M |
|---|---|
| Enterprise Value | $57.26M |
| Latest price (Nov 17, 2026) | $3.07 |
Key Dates
The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 10, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 91.70% over 52 weeks and trades 35.37% below its 50-day average.
| Beta (1Y) | 1.75 |
|---|---|
| 52-Week Change | -91.70% |
| 1-Month Change | -23.44% |
| 3-Month Change | -50.88% |
| 6-Month Change | -91.85% |
| Total Return (1Y) | -91.70% |
| Return vs SPY (1Y) | -103.71% |
| Max Drawdown (1Y) | -93.99% |
| Sharpe Ratio (1Y) | -1.00 |
| Correlation with SPY (1Y) | 0.09 |
| 50-Day Average | $4.75 |
| 200-Day Average | $27.82 |
| 52-Week Range | $3.10 to $54.97 |
| RSI (14 Days) | 28.8 |
| Average Volume (20 Days) | 829.14K |
Financial Position
Current assets cover 13.92x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 13.92x |
|---|---|
| Quick Ratio | 13.92x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -45.54% and return on assets is -41.60% over the last 12 months.
| Return on Equity (ROE) | -45.54% |
|---|---|
| Return on Assets (ROA) | -41.60% |
Scores
SION has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Gross Profit | -$152.00K |
| Operating Income | -$120.50M |
| Pretax Income | -$109.94M |
| Net Income | -$109.52M |
| Reported EPS (TTM) | -$2.44 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 91.36% of the $263.26M in total assets.
| Cash and Equivalents | $83.88M |
|---|---|
| Total Debt | $0 |
| Net Cash | $83.88M |
| Net Cash Per Share | $1.86 |
| Working Capital | $212.11M |
| Shareholder Equity | $240.52M |
| Book Value Per Share | $5.32 |
| Total Assets | $263.26M |
| Total Liabilities | $22.74M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$79.41M |
|---|---|
| FCF Per Share | -$1.76 |
| Depreciation and Amortization | $1.53M |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
SION does not pay a dividend.
| Buyback Yield | 0.42% |
|---|---|
| Shareholder Yield | 0.42% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About SION
What is SION's market cap?
Sionna Therapeutics, Inc. Common Stock has a market cap of $141.13M. Its enterprise value, which adds debt and subtracts cash, is $57.26M.
How many shares of SION are outstanding?
Sionna Therapeutics, Inc. Common Stock has 45.21M shares outstanding. The count is up 2.16% from a year earlier.
Does SION pay a dividend?
No. Sionna Therapeutics, Inc. Common Stock does not pay a dividend.
How much debt does SION have?
Sionna Therapeutics, Inc. Common Stock has $0 of total debt and $83.88M of cash and equivalents, a net cash position of $83.88M.
SION pages: Overview, Earnings, Forecast, Financials, Statistics, Competitors